234 related articles for article (PubMed ID: 38226611)
1. PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma.
Balraj AS; Muthamilselvan S; Raja R; Palaniappan A
Technol Cancer Res Treat; 2024; 23():15330338231222389. PubMed ID: 38226611
[TBL] [Abstract][Full Text] [Related]
2. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
3. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
4. Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer.
Johnston WL; Catton CN; Swallow CJ
BMC Urol; 2019 Jan; 19(1):4. PubMed ID: 30616540
[TBL] [Abstract][Full Text] [Related]
5. Development of a Deep Learning Algorithm for the Histopathologic Diagnosis and Gleason Grading of Prostate Cancer Biopsies: A Pilot Study.
Kott O; Linsley D; Amin A; Karagounis A; Jeffers C; Golijanin D; Serre T; Gershman B
Eur Urol Focus; 2021 Mar; 7(2):347-351. PubMed ID: 31767543
[TBL] [Abstract][Full Text] [Related]
6. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of modern Gleason 9/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland.
O'Kelly F; Elamin S; Cahill A; Aherne P; White J; Buckley J; O'Regan KN; Brady A; Power DG; O'Brien MF; Sweeney P; Mayer N; Kelly PJ
World J Urol; 2014 Aug; 32(4):1067-74. PubMed ID: 24129893
[TBL] [Abstract][Full Text] [Related]
8. Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Liu L; Li Y; Tang S; Yang B; Zhang Q; Xiao R; Hou X; Liu C; Ma L
Int J Biol Markers; 2023 Jun; 38(2):114-123. PubMed ID: 37192745
[TBL] [Abstract][Full Text] [Related]
9. Identification of Prognostic Biomarkers Associated with Cancer Stem Cell Features in Prostate Adenocarcinoma.
Zhang D; Zhang M; Zhang Q; Zhao Z; Nie Y
Med Sci Monit; 2020 Jul; 26():e924543. PubMed ID: 32735556
[TBL] [Abstract][Full Text] [Related]
10. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
[TBL] [Abstract][Full Text] [Related]
11. Grading of prostatic adenocarcinoma: current state and prognostic implications.
Gordetsky J; Epstein J
Diagn Pathol; 2016 Mar; 11():25. PubMed ID: 26956509
[TBL] [Abstract][Full Text] [Related]
12. Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.
Roberto D; Selvarajah S; Park PC; Berman D; Venkateswaran V
Prostate; 2019 Nov; 79(15):1777-1788. PubMed ID: 31503357
[TBL] [Abstract][Full Text] [Related]
13. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
14. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
15. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Artificial Intelligence Techniques to Evaluate Performance of a Classifier for Automatic Grading of Prostate Cancer From Digitized Histopathologic Images.
Nir G; Karimi D; Goldenberg SL; Fazli L; Skinnider BF; Tavassoli P; Turbin D; Villamil CF; Wang G; Thompson DJS; Black PC; Salcudean SE
JAMA Netw Open; 2019 Mar; 2(3):e190442. PubMed ID: 30848813
[TBL] [Abstract][Full Text] [Related]
17. Going deeper through the Gleason scoring scale: An automatic end-to-end system for histology prostate grading and cribriform pattern detection.
Silva-RodrÃguez J; Colomer A; Sales MA; Molina R; Naranjo V
Comput Methods Programs Biomed; 2020 Oct; 195():105637. PubMed ID: 32653747
[TBL] [Abstract][Full Text] [Related]
18. Automated gleason grading on prostate biopsy slides by statistical representations of homology profile.
Yan C; Nakane K; Wang X; Fu Y; Lu H; Fan X; Feldman MD; Madabhushi A; Xu J
Comput Methods Programs Biomed; 2020 Oct; 194():105528. PubMed ID: 32470903
[TBL] [Abstract][Full Text] [Related]
19. Seminal plasma metabolomics reveals lysine and serine dysregulation as unique features distinguishing between prostate cancer tumors of Gleason grades 6 and 7.
Falegan OS; Jarvi K; Vogel HJ; Hyndman ME
Prostate; 2021 Aug; 81(11):713-720. PubMed ID: 34097313
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
